Skip to content
DataLookout
Menu

NCT07939854

Stereotactic Aspiration Combined With Tenecteplase for Acute Pontine Hemorrhage

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Proportion of Participants With GCS Score >8
Timeframe: 90 days after randomization
All-Cause Mortality
Timeframe: Within 30 days after randomization.

Secondary (9)

7-Day All-Cause Mortality
Symptomatic Rebleeding
Intracranial Bacterial Infection
Serious Adverse Events (SAEs)
Adverse Events (AEs)
Show 4 moreShow less
Proportion With GCS Increase ≥3 Points
Proportion With Recovery of Consciousness
Proportion With mRS 0-3
Change in GCS Score Over Time

Arms and interventions

Stereotactic Aspiration Combined With TenecteplaseExperimental

Participants will receive neuronavigation-guided stereotactic hematoma aspiration followed by intralesional tenecteplase administration, in addition to standard medical treatment.

Standard Medical TreatmentActive comparator

Procedures: Neuronavigation-Guided Stereotactic Hematoma Aspiration

Drugs: Tenecteplase

Other: Standard Medical Treatment

Sites

1 site in 1 country

  • Beijing Tiantan Hospital, Capital Medical UniversityBeijing, Beijing Municipality, China